Correction to: Cell Discovery (2015) 1, 15040; doi:10.1038/celldisc.2015.40; published online 8 December 2015
In the initial published version of this article, there was an inadvertent omission from the Acknowledgements that the contribution of John P Cooke to this work was funded in part by a Core Facility Support Award from the Cancer Prevention and Research Institute of Texas (RP150611). This omission does not affect the description of the results or the conclusions of this paper.
Author information
Authors and Affiliations
Additional information
The online version of the original article can be found at 10.1038/celldisc.2015.40
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Bai, Y., Kan, S., Zhou, S. et al. Erratum: Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA. Cell Discov 2, 16032 (2016). https://doi.org/10.1038/celldisc.2016.32
Published:
DOI: https://doi.org/10.1038/celldisc.2016.32
